Nápoles MJD, Ortíz LD, Almeida LFA

Language: Spanish
References: 10
Page: 1-13
PDF size: 427.54 Kb.

ABSTRACT

Introduction: Venous thromboembolic disease has different clinical presentations; one of them is deep vein thrombosis, which may be in the range painful inflammatory Cerulean, constituting a clinically high severity.
Objective: To report the great complexity of the clinical condition of a patient with painful inflammatory cerulea after the termination of pregnancy by micro-cesarean section.
Case report: We describe a case of a 31-year-old patient with a personal medical history of essential chronic hypertension II. The successful result was related to an accurate diagnosis and effective therapy with thrombolytics in order to prevent bleeding that would endanger the life of this patient.
Conclusions: The thrombolytic treatment used after a diagnosis of painful inflammatory cerulea with arterial vasospasm is adequate given the risk of amputation and danger to life. In the case reported herein, favorable response was confirmed with the early use of streptokinase and the use of a dose/response scheme.

REFERENCES

1. Nápoles Méndez D. Profilaxis de la enfermedad tromboembólica venosa en el embarazo y puerperio en: Recomendación ante complicaciones no obstétrica de gestantes y puérperas. La Habana: ECIMED; 2017:23-34.

2. Peña Peralta LA, Mora Posada LR, Hernández Forero CG, Villegas González F. Tratamiento de Flegmasía Cerúlea Dolens con Trombólisis; Reporte de caso. Revista Cuarzo. 2018;24(2):44- 9.

3. Ramos Concepción EP. Tromboembolismo pulmonar. En: Diagnóstico y tratamiento en Medicina Interna. La Habana: Ecimed; 2012:215-27.

4. Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of Thrombosis and Thrombolysis. 2016;41(1):32-67. https://doi.org/10.1007/s11239-015-1317-0

5. Vallejo Hernández R, González MER, Gómez González P, Ortega Polar E, Panadero Carlavilla FJ. Oclusión arterial aguda. Panorama actual del medicamento. [Internet] 2016. [citado 13/05/2016];2016;40(399). Disponible en: https://dialnet.unirioja.es

6. Barrachina Hidalgo S, García Vila JH, Lorenzo Górriz A. Flegmasia cerúlea dolens, tratamiento endovascular. Rev Interv. 2018;18(3):111-4.

7. Yañéz Luque JE. Flegmasia cerúlea Dolens. Reporte de caso. Rev Med Hered. 2016;27:168-171.

8. Ceresetto JM. Fibrinolíticos en tromboembolismo pulmonar: ¿casi siempre o casi nunca? Lugar de los nuevos anticoagulantes orales. Número extraordinario XII Congreso del Grupo CAHT. Hematol. 2016;20:275-88.

9. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifková R, et al. Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol. 2019;72(2):161-5.

10. Lovesio C. Farmacoterapeútica en coagulación y trombosis. En: Lovesio C. Medicina intensiva. 6 ed. Rosario, Argentina: Corpus Libros Médicos y Científicos; 2008:1979-2010.